BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29180604)

  • 1. Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.
    Loree JM; Pereira AAL; Lam M; Willauer AN; Raghav K; Dasari A; Morris VK; Advani S; Menter DG; Eng C; Shaw K; Broaddus R; Routbort MJ; Liu Y; Morris JS; Luthra R; Meric-Bernstam F; Overman MJ; Maru D; Kopetz S
    Clin Cancer Res; 2018 Mar; 24(5):1062-1072. PubMed ID: 29180604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer.
    Salem ME; Battaglin F; Goldberg RM; Puccini A; Shields AF; Arguello D; Korn WM; Marshall JL; Grothey A; Lenz HJ
    Oncologist; 2020 May; 25(5):404-413. PubMed ID: 31848314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis.
    Chen TH; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Huang SC; Cheng HH; Chau GY; Hsia CY; Lei HJ; Chou SC; Chao Y; Teng HW
    J Gastrointest Surg; 2021 Mar; 25(3):650-661. PubMed ID: 33201458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study.
    Kuramochi H; Nakamura A; Nakajima G; Kaneko Y; Araida T; Yamamoto M; Hayashi K
    BMC Cancer; 2016 Jun; 16():366. PubMed ID: 27296289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.
    Salem ME; Weinberg BA; Xiu J; El-Deiry WS; Hwang JJ; Gatalica Z; Philip PA; Shields AF; Lenz HJ; Marshall JL
    Oncotarget; 2017 Oct; 8(49):86356-86368. PubMed ID: 29156800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.
    Loree JM; Bailey AM; Johnson AM; Yu Y; Wu W; Bristow CA; Davis JS; Shaw KR; Broaddus R; Banks KC; Lanman RB; Meric-Bernstam F; Overman MJ; Kopetz S; Raghav K
    J Natl Cancer Inst; 2018 Dec; 110(12):1409-1417. PubMed ID: 29718453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan.
    Taniguchi H; Uehara K; Nakayama G; Nakayama H; Aiba T; Hattori N; Kataoka M; Nakano Y; Kawase Y; Okochi O; Matsuoka H; Utsunomiya S; Sakamoto E; Mori Y; Umeda S; Shikano T; Komori K; Tajika M; Kadowaki S; Muro K; Yatabe Y
    Transl Oncol; 2020 Jul; 13(7):100786. PubMed ID: 32428838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
    Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C
    Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.
    Stintzing S; Tejpar S; Gibbs P; Thiebach L; Lenz HJ
    Eur J Cancer; 2017 Oct; 84():69-80. PubMed ID: 28787661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
    Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
    Jpn J Clin Oncol; 2024 Mar; ():. PubMed ID: 38535894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer.
    Dunne PD; O'Reilly PG; Coleman HG; Gray RT; Longley DB; Johnston PG; Salto-Tellez M; Lawler M; McArt DG
    Oncotarget; 2016 Jun; 7(24):36632-36644. PubMed ID: 27153559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer.
    Chowdhury S; Gupta R; Millstein J; Lin K; Haridas V; Zeineddine MA; Parseghian C; Lenz HJ; Kopetz S; Shen JP
    JCO Precis Oncol; 2023 Jul; 7():e2200422. PubMed ID: 37487150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer.
    Lal N; White BS; Goussous G; Pickles O; Mason MJ; Beggs AD; Taniere P; Willcox BE; Guinney J; Middleton GW
    Clin Cancer Res; 2018 Jan; 24(1):224-233. PubMed ID: 29061646
    [No Abstract]   [Full Text] [Related]  

  • 17. Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.
    Fontana E; Eason K; Cervantes A; Salazar R; Sadanandam A
    Ann Oncol; 2019 Apr; 30(4):520-527. PubMed ID: 30796810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study.
    Wu Y; Zhou J; Wang H; Fang G; Zhu W; Cai S; Wang L
    Hepatobiliary Surg Nutr; 2024 Apr; 13(2):214-228. PubMed ID: 38617480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomy.
    Yang JH; Lin WL; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Huang SC; Cheng HH; Yang YW; Lin YZ; Hsu HM; Lin CJ; Teng HW
    J Gastrointest Surg; 2024 May; ():. PubMed ID: 38782088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional proteomics of colon cancer Consensus Molecular Subtypes.
    Feliu J; Gámez-Pozo A; Martínez-Pérez D; Pérez-Wert P; Matamala-Luengo D; Viñal D; Kunz L; López-Vacas R; Dittmann A; Rodríguez-Salas N; Custodio A; Fresno Vara JÁ; Trilla-Fuertes L
    Br J Cancer; 2024 Jun; 130(10):1670-1678. PubMed ID: 38486123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.